ALKEMIST BIO
ALKemist Bio provides cell treatment to cancer patients.
ALKEMIST BIO
Social Links:
Industry:
Therapeutics
Founded:
2023-01-01
Address:
Turin, Piemonte, Italy
Country:
Italy
Website Url:
http://www.alkemistbio.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
6.9 M EUR
Technology used in webpage:
Google Google Cloud Wix
Similar Organizations
Century Therapeutics
Century Therapeutics is a developer of allogeneic living drugs created to offer treatment for cancer.
Garuda Therapeutics
Garuda Therapeutics is developing off-the-shelf hematopoietic stem cell (HSC) therapies to treat severe and life-threatening diseases.
Hava Health
Solving Nicotine Addiction Through Technology. A connected device that automatically adjusts nicotine intake.
Longevity Biotech
Longevity Biotech develops a new class of therapeutics via artificial protein technology that focuses on pharmaceutical preparation.
NBE-Therapeutics
NBE-Therapeutics is a biotech company that develops oncology treatments for cancer patients.
OYS Mobility
OYS Mobility develops prosthetic technology that allows people with limb loss or deformity to access healthcare and assistive devices.
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
Spotlight Therapeutics
Spotlight Therapeutics is a biotechnology company that develops biologics targeted to specific cell populations in gene editing.
T3 Pharmaceuticals
T3 Pharmaceuticals is to improve the lives of cancer patients with highly innovative treatments.
Tallac Therapeutics
Tallac Therapeutics offers next generation immunotherapies for cancer patients.
Investors List
Claris Ventures
Claris Ventures investment in Seed Round - ALKemist Bio
LIFTT
LIFTT investment in Seed Round - ALKemist Bio
Official Site Inspections
http://www.alkemistbio.com Semrush global rank: 11.54 M Semrush visits lastest month: 156
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.186
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "ALKemist Bio"
Home | Alkemist Bio
ALK-positive (ALK+) cancer has specific characteristics that unify these tumors regardless of where in the body they occur. ALK+ cancers are highly aggressive and tend to afflict a younger patient population ranging from pediatric …See details»
Management Team - Alkemist Bio
Roberto Chiarle is professor of Pathology at the Harvard Medical School and at the University of Turin. He oversees research laboratories both at the Boston Children’s Hospital and at the Molecular Biotechnology Center (MBC) of Turin, …See details»
ALKemist Bio - Crunchbase Company Profile & Funding
ALKemist Bio may be growing as it has recently secured a funding round of 6.9 million euros, led by Claris Ventures. This influx of capital suggests that the company has the financial …See details»
ALKEMIST BIO SRL Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for ALKEMIST BIO SRL of TORINO, TORINO. Get the latest business insights from Dun & Bradstreet.See details»
ALKemist Bio 2025 Company Profile: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for ALKemist Bio. Use the PitchBook Platform to explore the full profile.See details»
Board of Directors | Alkemist Bio
Dr. Hoess brings over three decades of leadership experience from across the biopharmaceutical industry and a significant commitment to the development of immuno-oncology therapeutics.See details»
ALKemist Bio - LinkedIn
At ALKemist Bio we are developing TCR-T cells that possess the ability to specifically target ALK antigens found on ALK-positive cancer cells, primarily focusing on non-small cell lung cancer ...See details»
LIFTT - ALKemist Bio
Category: Biotech www.alkemistbio.com [email protected] Torino, Italy ALKEMIST BIO ALKemist Bio emerges from the research conducted by Roberto Chiarle, Professor of …See details»
Alkemist Bio Srl - Drug pipelines, Patents, Clinical trials - Synapse
Explore Alkemist Bio Srl with its drug pipeline, therapeutic area, technology platform, 1 news.See details»
ALKemist Bio - Italian Angels for Growth
Next generation cell therapies for ALK-positive cancer patients. ALKemist Bio is a biotechnology company founded in Turin, Italy, in 2023. The company stems from the research of Professor …See details»
ALKemist Bio - Products, Competitors, Financials, Employees ...
ALKemist Bio focuses on the development of cell therapies for ALK-positive cancer patients. Use the CB Insights Platform to explore ALKemist Bio's full profile.See details»
alkemistbio.com Reviews | check if site is scam or legit| Scamadviser
Check alkemistbio.com with our free review tool and find out if alkemistbio.com is legit and reliable. Need advice? Report scams Check Scamadviser! Report a Scam Help & Info API & …See details»
Contact Us - Alkemist Bio
If you have any questions or would like more information about ALKemist Bio, contact us!See details»
ALKemist Bio Appoints Adi Hoess to Board of Directors
Dec 17, 2024 ALKemist Bio [email protected]. Media Inquiries: Trophic Communications Gretchen Schweitzer or Anja Heuer Phone: +49 172 861 8540 or +49 151 …See details»
News & Events - Alkemist Bio
Dec 17, 2024 ALKemist Bio appoints Adi Hoess to Board of Directors - December 17th, 2024See details»
Newly launched TCR company ALKemist Bio announces a €6.9M
Dec 21, 2023 ALKemist Bio emerges from the research conducted by Roberto Chiarle, Professor of pathology at the University of Turin and Director of the haemolymphopathology …See details»
ALKemist Bio Appoints Adi Hoess to Board of Directors
Dec 17, 2024 [email protected]. Media Inquiries: Trophic Communications Gretchen Schweitzer or Anja Heuer Phone: +49 172 861 8540 or +49 151 106 199 05 …See details»
Over 6 million euros to Alkemist Bio and cell therapy
Dec 29, 2023 ALKemist Bio develops cellular immunotherapies based on the engineering of cells from the patient’s immune system with T cell receptors (TCR-T cells), training them to …See details»
Approach - Alkemist Bio
About ALKemist Bio T cell-based therapies represent a revolutionary approach in the fight against solid cancers. Established treatments often face limitations, unable to fully address the …See details»
Team - Alkemist Bio
Home Care Services . Live-in Home Care. I'm a paragraph. Click here to add your own text and edit me. It’s easy. Just click “Edi t Text” or double click m e to add your own content and make …See details»